PMC:7600245 / 22583-22779
Annnotations
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T211","span":{"begin":159,"end":165},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"ate. The latter intermediate undergoes two phosphorylation steps mediated by the action of host kinases leading to the formation of the ribose-5′-triphosphate active form.\nFavipiravir is effective"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T312","span":{"begin":136,"end":142},"obj":"Chemical"},{"id":"T314","span":{"begin":146,"end":158},"obj":"Chemical"}],"attributes":[{"id":"A312","pred":"chebi_id","subj":"T312","obj":"http://purl.obolibrary.org/obo/CHEBI_33942"},{"id":"A313","pred":"chebi_id","subj":"T312","obj":"http://purl.obolibrary.org/obo/CHEBI_47013"},{"id":"A314","pred":"chebi_id","subj":"T314","obj":"http://purl.obolibrary.org/obo/CHEBI_18036"}],"text":"ate. The latter intermediate undergoes two phosphorylation steps mediated by the action of host kinases leading to the formation of the ribose-5′-triphosphate active form.\nFavipiravir is effective"}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T42","span":{"begin":43,"end":58},"obj":"http://purl.obolibrary.org/obo/GO_0016310"},{"id":"T43","span":{"begin":119,"end":128},"obj":"http://purl.obolibrary.org/obo/GO_0009058"}],"text":"ate. The latter intermediate undergoes two phosphorylation steps mediated by the action of host kinases leading to the formation of the ribose-5′-triphosphate active form.\nFavipiravir is effective"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T168","span":{"begin":5,"end":171},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ate. The latter intermediate undergoes two phosphorylation steps mediated by the action of host kinases leading to the formation of the ribose-5′-triphosphate active form.\nFavipiravir is effective"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"606","span":{"begin":136,"end":158},"obj":"Chemical"},{"id":"648","span":{"begin":172,"end":183},"obj":"Chemical"}],"attributes":[{"id":"A606","pred":"tao:has_database_id","subj":"606","obj":"MESH:C025202"},{"id":"A648","pred":"tao:has_database_id","subj":"648","obj":"MESH:C462182"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ate. The latter intermediate undergoes two phosphorylation steps mediated by the action of host kinases leading to the formation of the ribose-5′-triphosphate active form.\nFavipiravir is effective"}